CV301 Combined With PD-1/L1 Blockade in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Clinical trial NCT03628716 · COMPLETED
Trial details
- NCT number
- NCT03628716
- Sponsor
- Bavarian Nordic
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-18
- Primary completion
- 2020-11-03
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.